Open AccessSBRT Heightens Immune Response in Some Metastatic NSCLC Patients
Author(s) -
Kurt Samson
Publication year - 2019
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000616968.19323.04
Subject(s) - medicine , pembrolizumab , immunotherapy , lung cancer , oncology , nivolumab , radiation therapy , disease , chemotherapy , cancer , clinical trial